Showing results (41-50 of 95) with videos related to
Sort By:
Pageof 10
Natural Product Research|December 29, 2017
Forsskamide, a new ceramide from aerial parts of Forsskaolea tenacissima LinnHamdy K Assaf, Alaa M Nafady, Ahmed E Allam, et al.Viruses|January 22, 2021
Structural Mapping of Mutations in Spike, RdRp and Orf3a Genes of SARS-CoV-2 in Influenza Like Illness (ILI) PatientsBandar Alosaimi, Asif Naeem, Majed F Alghoribi, et al.Ultrastructural Pathology|July 17, 2023
The impact of busulfan on the testicular structure in prepubertal rats: A histological, ultrastructural and immunohistochemical studyReem Ibrahim Abd El-Hay, Walaa H E Hamed, Nesreen Mostafa Omar, et al.Journal of Basic Microbiology|January 19, 2026
Molecular Identification and Pathogenicity of Novel Tomato Root Rot Fungi, With Insights Into Cultivar Resistance in Saudi ArabiaKhalid E Hamed, Ali M Haddadi, Ayman F Omar, et al.Saudi Journal of Biological Sciences|July 17, 2023
Proinflammatory cytokine profiles in prediabetic Saudi patientsNouf O AlAfaleq, Tasneem M Hussein, Samia T Al-Shouli, et al.Circulation. Genomic and Precision Medicine|June 8, 2026
Performance of Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the All of Us ProgramJohanna L Smith, Kristjan Norland, Marwan E Hamed, et al.Circulation. Genomic and Precision Medicine|March 28, 2025
Effect of Disclosing a Polygenic Risk Score for Coronary Heart Disease on Adverse Cardiovascular EventsMohammadreza Naderian, Marwan E Hamed, Ali A Vaseem, et al.Chemistry & Biodiversity|September 29, 2023
New Cytotoxic Monoalkyl Glycerol Ether from the Red Sea Soft Coral Nephthea mollisAhmed H Eissa, Asmaa M Abdel-Tawab, El Sayed A E Hamed, et al.Natural Product Research|November 19, 2023
Cytotoxic evaluation of new polyhydroxylated steroids from the Red Sea soft coral <i>Litophyton mollis</i> (Macfadyen, 1936)Ahmed H Eissa, Asmaa M Abdel-Tawab, El Sayed A E Hamed, et al.Medrxiv : the Preprint Server for Health Sciences|July 29, 2024
Effect of disclosing a polygenic risk score for coronary heart disease on adverse cardiovascular events: 10-year follow-up of the MI-GENES randomized clinical trialMohammadreza Naderian, Marwan E Hamed, Ali A Vaseem, et al.Pageof 10